Savara Pharmaceuticals
SVRA
#6301
Rank
A$0.91 B
Marketcap
$5.58
Share price
4.72%
Change (1 day)
3.86%
Change (1 year)

Savara Pharmaceuticals (SVRA) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : A$56.18 M

According to Savara Pharmaceuticals's latest financial reports the company's total liabilities are A$56.18 M. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Savara Pharmaceuticals - Total liabilities on balance sheet (from 2002 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31A$54.58 M16.09%
2022-12-31A$47.02 M6.2%
2021-12-31A$44.27 M2.05%
2020-12-31A$43.38 M-11.96%
2019-12-31A$49.28 M-21.22%
2018-12-31A$62.55 M21.12%
2017-12-31A$51.64 M-42.56%
2016-12-31A$89.9 M115.97%
2015-12-31A$41.63 M187.71%
2014-12-31A$14.46 M73.43%
2013-12-31A$8.34 M67.4%
2012-12-31A$4.98 M0.64%
2011-12-31A$4.95 M179.24%
2010-12-31A$1.77 M-32.31%
2009-12-31A$2.62 M-60.79%
2008-12-31A$6.68 M66.57%
2007-12-31A$4.01 M27.29%
2006-12-31A$3.15 M-92.67%
2005-12-31A$42.98 M2629.99%
2004-12-31A$1.57 M617.78%
2003-12-31A$0.21 M-87.43%
2002-12-31A$1.74 M-2.84%
2001-12-31A$1.79 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
A$18 M-67.96%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.86 B 1,440.77%๐Ÿ‡บ๐Ÿ‡ธ USA